Blacksburg, VA, United States of America

Amy Wesa

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Precigen, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amy Wesa. Retrieved from https://idiyas.com/inventor/amy-wesa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Amy Wesa: Innovator in Cancer Therapy

Introduction

Amy Wesa is a prominent inventor based in Blacksburg, Virginia, known for her significant contributions to cancer therapy. She has developed innovative solutions that aim to improve treatment outcomes for patients suffering from proliferative disorders.

Latest Patents

Amy Wesa holds one patent titled "ROR-1 specific chimeric antigen receptors and uses thereof." This patent provides chimeric antigen receptors (CARs) specifically designed for cancer therapy. The CARs contain a single-chain variable fragment (scFv) derived from an anti-ROR-1 monoclonal antibody. The patent also details immune effector cells that incorporate these CARs and outlines methods for treating various proliferative disorders.

Career Highlights

Wesa's career is marked by her dedication to advancing cancer treatment through innovative research and development. She is currently associated with Precigen, Inc., where she continues to work on groundbreaking therapies that leverage her expertise in immunology and cellular engineering.

Collaborations

Amy collaborates with notable colleagues, including Rutul R Shah and ChangHung Chen, to further enhance the impact of her research in the field of cancer therapy.

Conclusion

Amy Wesa's work exemplifies the vital role of innovation in the fight against cancer. Her contributions through patents and collaborations are paving the way for new therapeutic approaches that could significantly benefit patients in need.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…